MDT (Medtronic) Cyclically Adjusted PB Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MDT Medtronic PLC MDT
84 GF Score
Price $92.13
GF Value $100.67
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Medtronic Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Medtronic  (NYSE:MDT) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Medtronic Cyclically Adjusted PB Ratio Related Terms


Medtronic Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Medtronic's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic Cyclically Adjusted PB Ratio Chart

Medtronic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.84 2.21 1.84 1.94 1.82

Medtronic Quarterly Data
Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26 Jul26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.04 2.05 2.35 1.80 1.90

MDT vs SYK, BSX, EW: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Medtronic's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medtronic Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Medtronic's Cyclically Adjusted PB Ratio falls into.


MDT
84GF Score
Medtronic PLC MDT
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medtronic Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Medtronic's Cyclically Adjusted Book per Share for the quarter that ended in Jul. 2026 is calculated as:

For example, Medtronic's adjusted Book Value per Share data for the three months ended in Jul. 2026 was:

Adj_Book=Book Value per Share/CPI of Jul. 2026 (Change)*Current CPI (Jul. 2026)
=39.725/128.7900*128.7900
=39.725

Current CPI (Jul. 2026) = 128.7900.

Medtronic Quarterly Data

Book Value per Share CPI Adj_Book
201610 36.629 99.776 47.281
201701 36.156 99.178 46.951
201704 36.815 100.773 47.051
201707 37.492 100.673 47.963
201710 38.105 100.374 48.893
201801 37.144 99.377 48.138
201804 37.529 100.374 48.154
201807 37.233 101.470 47.258
201810 36.930 101.271 46.965
201901 37.253 100.075 47.942
201904 37.452 102.068 47.257
201907 37.662 101.969 47.568
201910 37.839 101.969 47.792
202001 38.748 101.371 49.229
202004 37.934 101.969 47.912
202007 37.551 101.570 47.614
202010 37.394 100.474 47.933
202101 37.795 101.171 48.113
202104 38.354 103.065 47.927
202107 38.421 103.763 47.688
202110 38.784 105.557 47.320
202201 39.263 106.255 47.590
202204 39.618 110.242 46.284
202207 39.752 113.262 45.202
202210 39.136 115.315 43.709
202301 38.800 114.470 43.654
202304 38.822 118.213 42.296
202307 38.607 119.903 41.468
202310 38.827 121.111 41.289
202401 39.105 119.179 42.259
202404 38.449 121.232 40.846
202407 37.552 122.560 39.461
202410 37.984 121.956 40.112
202501 38.663 121.473 40.992
202504 37.643 123.888 39.132
202507 37.549 124.613 38.808
202510 38.110 125.410 39.137
202601 38.334 124.690 39.594
202604 39.113 128.430 39.223
202607 39.725 128.790 39.725

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Medtronic (MDT) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of $92.13 is trading 8.5% below its estimated GF Value™ of $100.67. GuruFocus considers Medtronic to be Fairly Valued.

Key valuation signals for MDT:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $100.67 vs. price of $92.13 (8.5% below fair value)
  • GF Score™: 84/100 with 3 warning signs

No single metric tells the full story. See the MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
84GF Score

Get the complete analysis for MDT

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$92.13
Price
$100.67
GF Value